Androgen deprivation therapy-associated hot flashes in prostate cancer
Conditions
Interventions
Sponsors
The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1) Histologic diagnosis of prostate cancer with a history of ADT use; 2) Experienced hot flashes at least a month before study entry; 3) Men 18 years or older with expectative life expectancy more than three months; 4) Willingness to participate in the study and sign informed consent; 5) Karnofsky Performance Status >= 60.
Exclusion criteria
Exclusion criteria: 1) Patients with a primary malignancy other than prostate cancer; 2) Under treatment for hot flashes control by using gabapentin, venlafaxine, etc.. 3) Unable to receive AA treatment and known allergy constitution; 4) Those who with severe heart, brain, kidney, liver, infectious or mental disease; 5) Difficulties in cooperating with the researchers and filling out the study documents.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hot Flash Score (HFS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life (QoL);Pittsburgh Sleep Quality Index (PSQI);Hamilton Anxiety Scale (HAS);Adverse events; | — |
Countries
China
Contacts
Public ContactZhichao Wang
The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine
Outcome results
None listed